Loss of muscle mass and limitations in activity have been reported in persons infected with human immunodeficiency virus (HIV), even those who are otherwise asymptomatic. The extent to which factors other than muscle atrophy impair muscle performance has not been addressed in depth. The purpose of this study was to determine the extent of neuromuscular activation of the knee extensors and ankle dorsiflexors of 27 men infected with HIV receiving antiretroviral therapy and its relationship to muscle performance. The central activation ratio (CAR) was determined using superimposed electrical stimulation during maximum voluntary contractions. In addition to force and power measurements, muscle cross-sectional area and composition was evaluated using computed tomography. Aerobic capacity was determined from treadmill exercise testing. Eleven of the subjects had an impaired ability to activate the knee extensors (CAR = 0.72 ± 0.12) that was associated with weakness and decreased specific force. The reduced central activation was not associated with muscle area, body composition, aerobic capacity, CD4 count, or medication regimen. Those individuals with low central activation had higher HIV-1 viral loads and were more likely to have a history of AIDS-defining illness. These results suggest the possibility of a different mechanism contributing to muscle impairment in the current treatment era that is associated with impairment of central motor function rather than atrophy. Further investigation is warranted in a larger, more diverse population before more definitive claims are made.Keywords central activation; electrical stimulation; HIV infection; muscle cross-sectional area Loss of skeletal muscle mass has a significant impact on functional performance, independent function, and associated quality of life in persons infected with the human immunodeficiency virus (HIV).1 , 36 Since highly active antiretroviral therapy (HAART) became the standard of care for HIV infection in 1995, the incidence of wasting (involuntary weight loss >10% ideal body weight) has declined, although it is still common.29 , 49 In the era of HAART, recent work indicates that HIV-associated weight loss is primarily due to fat 26,32 Identifying the factors beyond the reduction of muscle mass that contribute to impaired muscle function is required for optimizing the design of rehabilitation strategies to improve muscle strength and functional capacity in this chronically ill patient population.One factor that can reduce muscle force production in the absence of muscle atrophy is an impairment of central activation (i.e., the ability to activate the available muscle mass). Central activation failure has been shown to contribute significantly to muscle weakness in other clinical populations, e.g., in persons with osteoarthritis, cerebral palsy, or previous knee arthroplasty,14 , 31 , 39 and to negatively influence the relationship between muscle strength and physical function.14 The role of central activation in muscle performance in persons...